Planning Strategies Inc.’s United Therapeutics UTHR Stock Holding History

Planning Strategies Inc.’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$542	Buy	+1	New	+$563	﹤0.01%	846

Other funds holding UTHR

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return

PCM

Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

FAF

Fjarde Ap-fonden Stockholm, Sweden $20.9B AUM 36.93% 1-Year Est. Return

AIM

Achmea Investment Management Zeist, Netherlands $4B AUM 31.99% 1-Year Est. Return

Planning Strategies Inc.'s UTHR Position: Q2 2026 in Review

Planning Strategies Inc. opened a new position in United Therapeutics (UTHR) in Q2 2026: 1 share worth $542. The stake represents ﹤0.01% of the portfolio and ranks #846 among its holdings.

239 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

Planning Strategies Inc. held 1 share of United Therapeutics worth $542 as of Q2 2026.
United Therapeutics was a new Planning Strategies Inc. position in Q2 2026.
United Therapeutics made up ﹤0.01% of Planning Strategies Inc.'s portfolio in Q2 2026, its #846 holding.
239 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Planning Strategies Inc.'s 13F filing for Q2 2026, filed 27 Jul 2026.